Trial Outcomes & Findings for Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo (NCT NCT02046980)
NCT ID: NCT02046980
Last Updated: 2016-03-11
Results Overview
Recruitment status
COMPLETED
Study phase
PHASE2
Target enrollment
209 participants
Primary outcome timeframe
2 days
Results posted on
2016-03-11
Participant Flow
217 patients enrolled in the study but 8 retracted their agreements.
Participant milestones
| Measure |
Gufoni
Gufoni maneuver for apogeotropic horizontal benign paroxysmal positional vertigo (BPPV) at the first day
Gufoni
|
Vibration
Vibration maneuver for apogeotropic horizontal BPPV at the first day
Vibration
|
Sham
Sham maneuver for apogeotropic horizontal BPPV at the first day
Sham
|
|---|---|---|---|
|
Overall Study
STARTED
|
72
|
72
|
73
|
|
Overall Study
COMPLETED
|
70
|
67
|
72
|
|
Overall Study
NOT COMPLETED
|
2
|
5
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
Baseline characteristics by cohort
| Measure |
Gufoni
n=70 Participants
Gufoni maneuver for apogeotropic horizontal BPPV at the first day
Gufoni
|
Vibration
n=67 Participants
Vibration maneuver for apogeotropic horizontal BPPV at the first day
Vibration
|
Sham
n=72 Participants
Sham maneuver for apogeotropic horizontal BPPV at the first day
Sham
|
Total
n=209 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Lesion side
Left side
|
29 participants
n=5 Participants
|
30 participants
n=7 Participants
|
39 participants
n=5 Participants
|
98 participants
n=4 Participants
|
|
Age, Continuous
|
62.00 years
STANDARD_DEVIATION 11.58 • n=5 Participants
|
62.22 years
STANDARD_DEVIATION 13.25 • n=7 Participants
|
61.44 years
STANDARD_DEVIATION 13.48 • n=5 Participants
|
61.9 years
STANDARD_DEVIATION 12.7 • n=4 Participants
|
|
Sex: Female, Male
Female
|
42 Participants
n=5 Participants
|
39 Participants
n=7 Participants
|
52 Participants
n=5 Participants
|
133 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
28 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
76 Participants
n=4 Participants
|
|
Symptom duration
|
3.37 days
n=5 Participants
|
2.70 days
n=7 Participants
|
2.52 days
n=5 Participants
|
2.9 days
n=4 Participants
|
|
Lesion side
Right side
|
41 participants
n=5 Participants
|
37 participants
n=7 Participants
|
33 participants
n=5 Participants
|
111 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: 2 daysPopulation: 217 patients enrolled in the study but 8 retracted their agreements.
Outcome measures
| Measure |
Gufoni
n=70 Participants
Gufoni maneuver for apogeotropic horizontal BPPV at the first day
Gufoni
|
Vibration
n=67 Participants
Vibration maneuver for apogeotropic horizontal BPPV at the first day
Vibration
|
Sham
n=72 Participants
Sham maneuver for apogeotropic horizontal BPPV at the first day
Sham
|
|---|---|---|---|
|
Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus
|
51 participants
|
46 participants
|
38 participants
|
Adverse Events
Gufoni
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Vibration
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Sham
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place